Learn More
Tocris Bioscience™ Hydroxychloroquine sulfate

Autophagy inhibitor; also TLR9 inhibitor
Marke: Tocris Bioscience™ 5648/50
Beschreibung
Autophagy inhibitor. Inhibits growth and induces apoptosis of renal cancer cells in vitro. Also inhibits TLR9. Additionally inhibits PRC2 by inhibiting the allosteric binding of PRC2 to EED (embryonic ectoderm development) within the H3K27me3-binding pocket, and reduces H3K27me3 levels in multiple myeloma cells in vitro.
Hydroxychloroquine sulfate is an autophagy inhibitor. Also inhibits TLR9. Inhibits growth and induces apoptosis of renal cancer cells in vitro. Additionally inhibits PRC2 by inhibiting the allosteric binding of PRC2 to EED (embryonic ectoderm development) within the H3K27me3-binding pocket, and reduces H3K27me3 levels in multiple myeloma cells in vitro. Inhibits SARS-CoV-2 viral infection, in vitro (EC50 values in μM range and dependent on viral RNA copy number). Also antimalarial and immunomodulator.Tocris products are for biomedical research use only. They are not intended for human or veterinary use.
Spezifikation
| 2-[[4-[(7-Chloro-4-quinolinyl)amino]pentyl]ethylamino]ethanol sulfate | |
| 747-36-4 | |
| 50 mg |
Das Fisher Scientific Encompass-Programm bietet Artikel an, die nicht Teil unseres Vertriebsportfolios sind. Diese Produkte verfügen in der Regel nicht über Bilder oder detaillierte Beschreibungen. Wir sind jedoch bestrebt, Ihr Einkaufserlebnis zu verbessern. Bitte verwenden Sie das untenstehende Formular, um uns Feedback zum Inhalt dieses Produkts zu geben.